Member Info for Morgank

Yes best board i have followed with genuine belief in a stock that we must all agree is going to bring home the bacon in the not to distant future. GLA. Thanks for the hard work researching every aspect of this tech.

Great to see a 4 handle again, lets hope we have seen the back of 3 for good this time

What does it take to move this SP ??

And there’s more, 1.6 m 800k 500k 500k

10m trade, buy @ 4 just gone through !

You seem to be sure their out but don’t seem to be able to give the evidence to support what you say

On what do you base that ?

Milton had 3.95% end of June by SEE website, do we have confirmation this holding has been sold out, if so should have been notification

Angle PLC Use of Parsortix in head and neck cancer

Source: RNS Non-Regulatory
TIDMAGL

Angle PLC

13 September 2019


For immediate release 13 September 2019

ANGLE plc ("the Company")

PUBLICATION ON USE OF PARSORTIX IN HEAD AND NECK CANCER

Opportunity for Parsortix to be used for PD-L1 analysis of CTCs to assess whether patients will benefit from immunotherapies

Over 1 mil traded today

SP will get there, just have to be patient a little longer, today the SP rose then sellers moved in but unlike other days the SP recovered again so hopeful it can move up steadily over coming months

SP target reaffirmed yesterday @ 135

Angle PLC Research with Parsortix in prostate cancer

Source: UK Regulatory (RNS & others)
TIDMAGL

RNS Number : 7335L

Angle PLC

10 September 2019


For immediate release 10 September 2019

ANGLE plc ("the Company")

BREAKTHROUGH RESEARCH DEMONSTRATES A PARSORTIX TEST COULD AVOID UNNECESSARY PROSTATE BIOPSIES

Barts Cancer Institute demonstrates capability of Parsortix system to detect clinically significant prostate cancer to reduce over-diagnosis and over-treatment

Positive GLA

Ken says he still has 8m shares so i guess he still has confidence in his former company’s prospects, look forward to further comment

Looks ok to me, and your insight is very welcome to investors here

Yes welcome KK

It happens allot often before news is released , others get to know first , buy and then sell into the release

Buying into the close !

Angle PLC Parsortix for Neuroendocrine Analysis in SCLC

Source: RNS Non-Regulatory
TIDMAGL

Angle PLC

04 September 2019


For immediate release 4 September 2019

ANGLE plc ("the Company")

MEDICAL UNIVERSITY OF VIENNA DEMONSTRATES USE OF PARSORTIX FOR NEUROENDOCRINE ANALYSIS IN SMALL CELL LUNG CANCER